Edwards Lifesciences Corporation
EW · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $6.07B | $5.44B | +11.5% |
| Operating income | $1.26B | $1.38B | −8.3% |
| Net income | $1.07B | $4.17B | −74.3% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $1.72B | $1.55B | +10.5% |
| Operating income | $299M | $307M | −2.6% |
| Net income | $308M | $291M | +5.6% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Edwards's revenue in FY2025?
- $6.07B in FY2025 (Fiscal year ended Dec 31, 2025), +11.5% vs $5.44B a year earlier, per its 10-K filed Feb 2026.
- Was Edwards profitable in FY2025?
- Yes: net income was $1.07B and operating income $1.26B in FY2025.
- What was Edwards's revenue in Q3 2026?
- $1.72B (+10.5% vs a year earlier), per its Form 10-Q filed Nov 4, 2026.